1. Home >
  2. M&A >
  3. Stake Purchase >
  4. United States >
  5. Georgia >
  6. EW Healthcare Partners and Hayfin Invest In MiMedx

Investment Summary

EW Healthcare Partners and Hayfin Invest In MiMedx

On July 2, 2020, growth capital firm EW Healthcare Partners and Hayfin invested in life science company MiMedx

Investment Highlights
  • This is EW Healthcare Partners’ 17th and Hayfin’s 1st transaction in the Life Science sector.
  • This is EW Healthcare Partners’ 49th and Hayfin’s 2nd transaction in the United States.
  • This is EW Healthcare Partners’ 2nd and Hayfin’s 1st transaction in Georgia.

Investment Summary
Date 2020-07-02
Target MiMedx
Sector Life Science
Investor(s) EW Healthcare Partners
Hayfin
Deal Type Stake Purchase

Target

MiMedx

Marietta, Georgia, United States
MiMedx is an advanced wound care and an emerging therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx was formed in 2011 and is based in Marietta, Georgia.

Search 205,819 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

EW Healthcare Partners

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.

DEAL STATS #
Overall 55 of 59
Sector (Life Science) 17 of 20
Type (Stake Purchase) 4 of 6
State (Georgia) 2 of 2
Country (United States) 49 of 50
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-16 Proteus Digital Health

Redwood City, California, United States

Proteus Digital Health is a developer of digital products that collect and aggregate various behavioral, physiological and therapeutic metrics. Proteus Digital Health is based in Redwood City, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-10 Cota

New York, New Jersey, United States

Cota, Inc. is a provider of health care informatics and precision analytics company that builds research-grade, real-world data to exponentially improve outcomes, reduce cost and ensure the right care for the right patient every time. Cota was founded in 2011 and is based in New York City.

Sell -
Investor

Hayfin

London, United Kingdom
Category Company
Founded 2009
Sector Business Services
DESCRIPTION

Hayfinis an independent investment firm that offers lending solutions to European middle-market companies and asset management services to institutional clients. Hayfinis was formed in 2009 and is based in London.

DEAL STATS #
Overall 5 of 5
Sector (Life Science) 1 of 1
Type (Stake Purchase) 1 of 1
State (Georgia) 1 of 1
Country (United States) 2 of 2
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-16 Novartis AG - TOBRADEX & NATACYN

Basel, Switzerland

Novartis AG's TOBRADEX is a fixed-dose topical antibiotic and corticosteroid combination indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Novartis AG's NATACYN is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-27 Grupo Itevelesa

Madrid, Spain

Grupo Itevelesa is an independent company of technical inspection of vehicles. operates 72 fixed locations and 20 mobile units across 11 autonomous communities; it also provides industrial safety, metrology, and environmental inspection services. Grupo Itevelesa was founded in 1982 and is based in Madrid, Spain.

Sell -
Mergr

Product

Company

Legal